PRESS RELEASE

Q4 2020 — Press release

Q4 2020PDF · 8 pages411 KB
FOR IMMEDIATE RELEASE
CME Group Inc. Reports Fourth-Quarter and Full-Year 2020 Financial Results
CHICAGO, February 10, 2021 - CME Group Inc. (NASDAQ: CME) today reported
financial results for the fourth quarter and full year of 2020.
The company reported revenue of $1.1 billion and operating income of $515 million for
the fourth quarter of 2020. Net income was $424 million and diluted earnings per share were
$1.18. On an adjusted basis, net income was $497 million and diluted earnings per share were
$1.39. Financial results presented on an adjusted basis for the fourth quarter of 2020 and 2019
exclude certain items, which are detailed in the reconciliation of non-GAAP results. 1
Total revenue for full-year 2020 was $4.9 billion and operating income was $2.6 billion.
Net income was $2.1 billion and diluted earnings per share were $5.87. On an adjusted basis,
net income was $2.4 billion, and diluted earnings per share were $6.72.
"As the ongoing global pandemic created an environment of extreme uncertainty and
market volatility, we remained highly focused on helping our clients manage risk that was
impacting their businesses," said CME Group Chairman and Chief Executive Officer Terry Duffy.
"Despite the challenges, we achieved record international volume during full-year 2020 and saw
strong, double-digit, year-over-year growth in the fourth quarter across our Equity Index and
Agricultural businesses. Since the start of 2021, we completed the migration of our BrokerTec
business to CME Globex, unlocking additional value and cost efficiencies for our clients who
can now access listed derivatives, cash and repo markets on a common platform. Looking
ahead, we will continue to deliver innovative products that can address our clients' evolving
needs, including Q1 launches for Ether futures, Global Emissions Offset futures and Japanese
energy futures."
Fourth-quarter 2020 average daily volume (ADV) was 16.2 million contracts. Non-U.S.
ADV for full-year 2020 reached a record 5.3 million contracts.
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of
GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.
- more -
Media contact 	Investor contact
Chris Grams, 312.930.3435 	John Peschier, 312.930.8491
Laurie Bischel, 312.648.8698 	CME-G
news@cmegroup.com
www.cmegroup.mediaroom.com

-- 1 of 8 --

Page 2
Clearing and transaction fees revenue for fourth-quarter 2020 totaled $843 million. The
total average rate per contract was $0.699. Market data revenue totaled $140 million for fourth-
quarter 2020.
As of December 31, 2020, the company had approximately $1.7 billion in cash (including
$100 million deposited with Fixed Income Clearing Corporation (FICC) and included in other
current assets) and $3.4 billion of debt. The company declared dividends during 2020 of
$2.1 billion, including the annual variable dividend of $895 million. The company has returned
over $15.3 billion to shareholders in the form of dividends since the implementation of the
variable dividend policy in early 2012.
CME Group will hold a Q&A conference call to discuss fourth-quarter 2020 results
at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on
the Investor Relations section of CME Group’s website at www.cmegroup.com. An
archived recording will be available for up to two months after the call.
As the world's leading and most diverse derivatives marketplace, CME Group
(www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize
portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and
capture opportunities. CME Group exchanges offer the widest range of global benchmark products across
all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural
products and metals. The company offers futures and options on futures trading through the CME
Globex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform.
In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.
With a range of pre- and post-trade products and services underpinning the entire lifecycle of a trade,
CME Group also offers optimization and reconciliation services through TriOptima, and trade processing
services through Traiana.
CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are
trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of
Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are
trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc.
BrokerTec, EBS, TriOptima, and Traiana are trademarks of BrokerTec Europe LTD, EBS Group LTD,
TriOptima AB, and Traiana, Inc., respectively. Dow Jones, Dow Jones Industrial Average, S&P 500 and
S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial
Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by
Chicago Mercantile Exchange Inc. All other trademarks are the property of their respective owners.
- more -

-- 2 of 8 --

Page 3
Statements in this press release that are not historical facts are forward-looking statements.
These statements are not guarantees of future performance and involve risks, uncertainties and
assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from
what is expressed or implied in any forward-looking statements. We want to caution you not to place
undue reliance on any forward-looking statements. We undertake no obligation to publicly update any
forward-looking statements, whether as a result of new information, future events or otherwise. Among
the factors that might affect our performance are increasing competition by foreign and domestic entities,
including increased competition from new entrants into our markets and consolidation of existing entities;
our ability to keep pace with rapid technological developments, including our ability to complete the
development, implementation and maintenance of the enhanced functionality required by our customers
while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our
ability to continue introducing competitive new products and services on a timely, cost-effective basis,
including through our electronic trading capabilities, and our ability to maintain the competitiveness of our
existing products and services, including our ability to provide effective services to the swaps market; our
ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing
customers at substantially similar trading levels, develop strategic relationships and attract new
customers; our ability to expand and globally offer our products and services; changes in regulations,
including the impact of any changes in laws or government policies with respect to our products or
services or our industry, such as any changes to regulations and policies that require increased financial
and operational resources from us or our customers; the costs associated with protecting our intellectual
property rights and our ability to operate our business without violating the intellectual property rights of
others; decreases in revenue from our market data as a result of decreased demand or changes to
regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products
traded, the trading venue and the mix of customers (whether the customer receives member or non-
member fees or participates in one of our various incentive programs) and the impact of our tiered pricing
structure; the ability of our credit and liquidity risk management practices to adequately protect us from
the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity
requirements associated with the BrokerTec matched principal business; the ability of our compliance and
risk management methods to effectively monitor and manage our risks, including our ability to prevent
errors and misconduct and protect our infrastructure against security breaches and misappropriation of
our intellectual property assets; our dependence on third-party providers and exposure to risk through
third parties, including risks related to the performance, reliability and security of technology used by our
third-party providers; volatility in commodity, equity and fixed income prices, and price volatility of financial
benchmarks and instruments such as interest rates, credit spreads, equity indices, fixed income
instruments and foreign exchange rates; economic, social, political and market conditions, including the
volatility of the capital and credit markets and the impact of economic conditions on the trading activity of
our current and potential customers; the impact of the COVID-19 pandemic and response by
governments and other third parties; our ability to accommodate increases in contract volume and order
transaction traffic and to implement enhancements without failure or degradation of the performance of
our trading and clearing systems; our ability to execute our growth strategy and maintain our growth
effectively; our ability to manage the risks, control the costs and achieve the synergies associated with
our strategy for acquisitions, investments and alliances, including those associated with NEX; our ability
to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our
business; industry and customer consolidation; decreases in trading and clearing activity; the imposition
of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax
treatment of such transactions; our ability to maintain our brand and reputation; and the unfavorable

-- 3 of 8 --

resolution of material legal proceedings. For a detailed discussion and additional information concerning
these and other factors that might affect our performance, see our filings with the Securities and
Exchange Commission, including our most recent periodic reports filed on Form 10-K and Form 10-Q.
# # #

-- 4 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
December 31, 2020 	December 31, 2019
ASSETS
Current Assets:
Cash and cash equivalents 	$ 	1,633.2 	$ 	1,551.4
Marketable securities 	100.9 	83.2
Accounts receivable, net of allowance 	461.3 	491.8
Other current assets (includes $4.7 and $4.3 in restricted cash) 	306.7 	364.4
Performance bonds and guaranty fund contributions 	86,781.8 	37,077.0
Total current assets 	89,283.9 	39,567.8
Property, net of accumulated depreciation and amortization 	579.2 	544.0
Intangible assets—trading products 	17,175.3 	17,175.3
Intangible assets—other, net 	4,865.3 	5,117.7
Goodwill 	10,798.8 	10,742.5
Other assets (includes $0.6 and $0.9 in restricted cash) 	1,957.1 	2,068.0
Total Assets 	$ 	124,659.6 	$ 	75,215.3
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable 	$ 	69.3 	$ 	61.9
Other current liabilities 	1,346.8 	1,384.8
Performance bonds and guaranty fund contributions 	86,781.8 	37,075.8
Total current liabilities 	88,197.9 	38,522.5
Long-term debt 	3,443.8 	3,743.2
Deferred income tax liabilities, net 	5,607.0 	5,635.2
Other liabilities 	1,059.4 	1,155.1
Total Liabilities 	98,308.1 	49,056.0
CME Group Shareholders’ Equity 	26,319.9 	26,128.9
Non-controlling interests 	31.6 	30.4
Total Equity 	26,351.5 	26,159.3
Total Liabilities and Equity 	$ 	124,659.6 	$ 	75,215.3

-- 5 of 8 --

CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
December 31,
Year Ended
December 31,
2020 	2019 	2020 	2019
Revenues
Clearing and transaction fees 	$ 	843.0 	$ 	901.0 	$ 3,897.4 	$ 3,946.1
Market data and information services 	139.8 	130.3 	545.4 	518.5
Other 	115.7 	107.1 	440.8 	403.4
Total Revenues 	1,098.5 	1,138.4 	4,883.6 	4,868.0
Expenses
Compensation and benefits 	215.6 	217.6 	856.5 	898.7
Technology 	53.6 	53.1 	198.5 	201.5
Professional fees and outside services 	50.0 	49.8 	191.3 	174.1
Amortization of purchased intangibles 	79.0 	78.1 	311.2 	314.7
Depreciation and amortization 	41.5 	38.0 	153.2 	158.6
Licensing and other fee agreements 	57.9 	41.3 	244.9 	172.2
Other 	85.9 	87.5 	290.6 	360.4
Total Expenses 	583.5 	565.4 	2,246.2 	2,280.2
Operating Income 	515.0 	573.0 	2,637.4 	2,587.8
Non-Operating Income (Expense)
Investment income 	31.1 	147.6 	182.7 	637.9
Interest and other borrowing costs 	(41.7) 	(42.0) 	(166.2) 	(178.0)
Equity in net earnings (losses) of unconsolidated
subsidiaries 	46.6 	44.5 	190.6 	176.8
Other non-operating income (expense) 	(16.0) 	(99.0) 	(122.4) 	(534.9)
Total Non-Operating Income (Expense) 	20.0 	51.1 	84.7 	101.8
Income before Income Taxes 	535.0 	624.1 	2,722.1 	2,689.6
Income tax provision 	110.2 	155.1 	615.7 	573.8
Net Income 	424.8 	469.0 	2,106.4 	2,115.8
Less: net (income) loss attributable to non-controlling
interests 	(0.8) 	0.5 	(1.2) 	0.7
Net Income Attributable to CME Group 	$ 	424.0 	$ 	469.5 	$ 2,105.2 	$ 2,116.5
Earnings per Common Share Attributable to CME
Group:
Basic 	$ 	1.18 	$ 	1.31 	$ 	5.88 	$ 	5.93
Diluted 	1.18 	1.31 	5.87 	5.91
Weighted Average Number of Common Shares:
Basic 	358,047 	357,456 	357,764 	357,155
Diluted 	358,612 	358,354 	358,524 	358,239

-- 6 of 8 --

CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
4Q 2019 	1Q 2020 	2Q 2020 	3Q 2020 	4Q 2020
Trading Days 	64 	62 	63 	64 	64
Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
Product Line 	4Q 2019 	1Q 2020 	2Q 2020 	3Q 2020 	4Q 2020
Interest rates 	8,638 	13,813 	6,890 	5,315 	6,273
Equity indexes 	3,252 	6,498 	5,568 	5,410 	5,148
Foreign exchange 	839 	1,079 	725 	829 	818
Energy 	2,213 	3,228 	2,586 	1,852 	1,940
Agricultural commodities 	1,278 	1,506 	1,311 	1,372 	1,478
Metals 	652 	889 	519 	825 	568
Total 	16,872 	27,013 	17,599 	15,603 	16,225
Venue
CME Globex 	15,356 	24,582 	16,992 	15,054 	15,469
Open outcry (2) 867 	1,281 	— 	108 	273
Privately negotiated 	650 	1,149 	607 	441 	483
Total 	16,872 	27,013 	17,599 	15,603 	16,225
Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
Product Line 	4Q 2019 	1Q 2020 	2Q 2020 	3Q 2020 	4Q 2020
Interest rates 	$ 	0.507 	$ 	0.488 	$ 	0.510 	$ 	0.506 	$ 	0.490
Equity indexes 	0.654 	0.616 	0.574 	0.525 	0.523
Foreign exchange 	0.732 	0.721 	0.786 	0.763 	0.739
Energy 	1.133 	1.108 	1.191 	1.171 	1.165
Agricultural commodities 	1.242 	1.260 	1.316 	1.284 	1.301
Metals 	1.344 	1.429 	1.518 	1.309 	1.389
Average RPC 	$ 	0.717 	$ 	0.676 	$ 	0.731 	$ 	0.716 	$ 	0.699
1. ADV and RPC includes futures and options on futures only.
2. Due to the COVID-19 pandemic, in March 2020 we closed our open outcry trading floor and reopened it in August
2020 for Eurodollar options. Currently, the remainder of the trading floor is closed.

-- 7 of 8 --

CME Group Inc. and Subsidiaries
Reconciliation of GAAP to non-GAAP Measures
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended
December 31,
Year Ended
December 31,
2020 	2019 	2020 	2019
Net Income Attributable to CME Group 	$ 	424.0 	$ 	469.5 	$ 2,105.2 	$ 	2,116.5
Restructuring and severance 	5.5 	6.4 	22.1 	20.8
Amortization of purchased intangibles 	79.0 	78.1 	311.2 	314.7
Litigation matters 	0.8 	— 	8.2 	—
Acquisition-related costs(1) 	16.2 	8.6 	42.6 	31.3
Foreign exchange transaction losses 	6.9 	5.5 	9.3 	7.2
Acceleration of contractual commitments 	— 	— 	— 	(1.3)
Unrealized and realized (gains) losses on investments 	0.5 	(18.3) 	6.8 	1.8
Loss on real estate sublease and related costs 	— 	0.5 	— 	5.9
(Gains) Losses on derivatives 	— 	(0.2) 	(1.5) 	17.7
Realized and unrealized losses on assets(2) 	4.3 	2.9 	33.1 	81.7
Trading floor enhancements 	— 	— 	2.5 	—
Income tax effect related to above 	(24.2) 	(6.4) 	(109.9) 	(99.7)
Other income tax items(3) 	(15.9) 	(2.2) 	(18.5) 	(62.2)
Adjusted Net Income Attributable to CME Group 	$ 	497.1 	$ 	544.4 	$ 	2,411.1 	$ 	2,434.4
GAAP Earnings per Common Share Attributable to
CME Group:
Basic 	$ 	1.18 	$ 	1.31 	$ 	5.88 	$ 	5.93
Diluted 	1.18 	1.31 	5.87 	5.91
Adjusted Earnings per Common Share Attributable
to CME Group:
Basic 	$ 	1.39 	$ 	1.52 	$ 	6.74 	$ 	6.82
Diluted 	1.39 	1.52 	6.72 	6.80
Weighted Average Number of Common Shares:
Basic 	358,047 	357,456 	357,764 	357,155
Diluted 	358,612 	358,354 	358,524 	358,239
1. Acquisition-related costs primarily include professional fees related to the NEX transaction.
2. Results include net gains and losses on intangible assets, fixed assets and assets held for sale.
3. Other income tax items include the income tax impacts related primarily to the remeasurement of tax positions
resulting from state and local income tax changes
21-15

-- 8 of 8 --